Published in J Mol Cell Cardiol on January 01, 1989
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol (2000) 1.21
Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br J Pharmacol (2005) 0.99
Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart. Br J Pharmacol (2002) 0.98
The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol (2002) 0.98
The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation. Br J Pharmacol (2002) 0.90
Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Br J Pharmacol (1999) 0.87
Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts. Br J Pharmacol (1993) 0.86
An endogenous protectant effect of cardiac cyclic GMP against reperfusion-induced ventricular fibrillation in the rat heart. Br J Pharmacol (1995) 0.85
Electrophysiological mechanisms for antiarrhythmic efficacy and positive inotropy of liriodenine, a natural aporphine alkaloid from Fissistigma glaucescens. Br J Pharmacol (1996) 0.83
Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts. Br J Pharmacol (2006) 0.83
Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methyl-neocaryachine, in rat heart. Br J Pharmacol (2002) 0.82
Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Br J Pharmacol (1999) 0.81
Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids. Br J Pharmacol (2013) 0.80
Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol (1995) 0.80
Complex adrenergic and inflammatory mechanisms contribute to phase 2 ventricular arrhythmias in anaesthetized rats. Br J Pharmacol (2009) 0.79
Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death. J Am Soc Hypertens (2010) 0.78
Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation? Br J Pharmacol (2006) 0.78
Reperfusion-induced sustained ventricular tachycardia, leading to ventricular fibrillation, in chronically instrumented, intact, conscious mice. Physiol Rep (2014) 0.78
The electrophysiological effects of antiarrhythmic potential of a secoaporphine, N-allylsecoboldine. Br J Pharmacol (1994) 0.76
Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo. Br J Pharmacol (1999) 0.75
Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart. Br J Pharmacol (2014) 0.75
Poster communications. Br J Pharmacol (1993) 0.75
Electrophysiological basis for antiarrhythmic efficacy, positive inotropy and low proarrhythmic potential of (-)-caryachine. Br J Pharmacol (1995) 0.75
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res (1994) 2.16
Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol (1984) 2.00
The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol (1978) 1.95
Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res (1987) 1.83
Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol (1973) 1.77
Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74
Reperfusion of the ischemic myocardium. J Mol Cell Cardiol (1977) 1.74
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol (1999) 1.61
Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol (1977) 1.61
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res (1986) 1.52
The influence of some physico-chemical factors on the biliary excretion of a series of structurally related aryl sulphate esters. Biochem Pharmacol (1969) 1.51
Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol (1979) 1.48
The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins. Cardiovasc Res (1993) 1.46
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. J Thorac Cardiovasc Surg (1989) 1.43
Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. J Thorac Cardiovasc Surg (1988) 1.43
Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res (1984) 1.39
Harvesting hearts for long-term preservation. Detrimental effects of initial hypothermic infusion of cardioplegic solutions. J Thorac Cardiovasc Surg (1990) 1.38
Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol (1987) 1.35
The isolated blood and perfusion fluid perfused heart. Pharmacol Res (2000) 1.34
Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand Suppl (1986) 1.26
Hypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res (1975) 1.25
The role of glucose in the survival and 'recovery' of the anoxic isolated perfused rat heart. Biochem J (1972) 1.20
The "border zone" in evolving myocardial infarction: controversy or confusion? Am J Cardiol (1981) 1.14
Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg (1989) 1.13
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochem J (1973) 1.12
Creatine kinase isoenzymes: their separation and quantitation. Cardiovasc Res (1977) 1.12
Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg (1977) 1.09
Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res (1993) 1.08
Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res (1987) 1.08
Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors. Circ Res (1999) 1.07
Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol (1975) 1.06
Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol (1989) 1.04
Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation (1976) 1.03
Enzyme release during myocardial anoxia: a study of metabolic protection. J Mol Cell Cardiol (1975) 1.01
Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am J Physiol (1989) 1.00
Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequences of various cardioplegic procedures in the isolated rat heart. Circ Res (1974) 0.99
The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species. Eur J Cardiol (1978) 0.99
Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg (1977) 0.98
Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.97
Temporal and spatial characteristics of evolving cell injury during regional myocardial ischemia in the dog: the "border zone" controversy. J Am Coll Cardiol (1983) 0.96
Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res (1992) 0.96
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. Am J Cardiol (1983) 0.94
Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest. Ann Thorac Surg (1999) 0.94
Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol (1975) 0.94
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol (1987) 0.94
The metabolic fate and elimination of streptozotocin. Biochem Soc Trans (1975) 0.94
Verapamil and the calcium paradox. J Mol Cell Cardiol (1980) 0.93
"Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol (1993) 0.93
The temperature dependence of the calcium paradox: enzymatic, functional and morphological correlates of cellular injury. J Mol Cell Cardiol (1983) 0.92
Reperfusion-induced arrhythmias and free radicals: studies in the rat heart with DMPO. J Cardiovasc Pharmacol (1987) 0.91
Preconditioning and reperfusion arrhythmias in the isolated rat heart: true protection or temporal shift in vulnerability? Cardiovasc Res (1993) 0.91
Reperfusion arrhythmias: dose-related protection by anti-free radical interventions. Am J Physiol (1989) 0.90
Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res (1996) 0.90
Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms. J Thorac Cardiovasc Surg (1985) 0.90
Reperfusion-induced arrhythmias: mechanisms of protection by glucose and mannitol. Am J Physiol (1988) 0.90
The synthesis of [14C] streptozotocin and its distribution and excretion in the rat. Biochem J (1974) 0.89
Characterization of the lateral interface between normal and ischemic tissue in the canine heart during evolving myocardial infarction. Am J Cardiol (1981) 0.89
Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc Res (1992) 0.89
Cardioplegia and slow calcium-channel blockers. Studies with verapamil. J Thorac Cardiovasc Surg (1983) 0.88
Calcium antagonists and hypothermia: the temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart. Circulation (1984) 0.88
Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs. J Mol Cell Cardiol (1983) 0.87
Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardioscience (1991) 0.87
Species variation in myocardial anoxic enzyme release, glucose protection and reoxygenation damage. J Mol Cell Cardiol (1976) 0.87
Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation (1997) 0.86
Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart. J Thorac Cardiovasc Surg (1987) 0.86
Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann Thorac Surg (1987) 0.86
Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats. J Cardiovasc Pharmacol (1993) 0.86
Regional myocardial ischemia: characterization of temporal, transmural and lateral flow interfaces in the porcine heart. Can J Cardiol (1986) 0.86
Effects of R-56865 on transient inward current, Na(+)-Ca2+ exchange, and Ca2+ release from SR in cardiac myocytes. Am J Physiol (1994) 0.85
Protection of the myocardium during ischemic arrest: possible toxicity of carnitine in cardioplegic solutions. Thorac Cardiovasc Surg (1980) 0.85
The preparation and characterization of a series of 35S-labelled aryl sulphate esters for metabolic studies. Biochem Pharmacol (1969) 0.85
Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine. J Cardiovasc Pharmacol (1987) 0.85
Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat. Circulation (1992) 0.85
Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg (1978) 0.85
N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics. Drug Metab Dispos (1976) 0.84
Microbiopsy metabolite and paired flow analysis: a new rapid procedure for homogenisation, extraction and analysis of high energy phosphates and other intermediates without any errors from tissue loss. Cardiovasc Res (1984) 0.84
Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart. Circulation (1992) 0.84
Na+/H+ exchanger inhibitor HOE-642 improves cardioplegic myocardial preservation under both normothermic and hypothermic conditions. Circulation (1997) 0.84
Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol (1992) 0.84
Protection of the ischemic myocardium. Ultrastructural, enzymatic, and functional assessment of the efficacy of various cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.84
The St. Thomas' hospital cardioplegic solution: a characterization in two species. Scand J Thorac Cardiovasc Surg Suppl (1981) 0.84
Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: reduction or delay? Am J Cardiol (1983) 0.84
Singlet oxygen and myocardial injury: ultrastructural, cytochemical and electrocardiographic consequences of photoactivation of rose bengal. J Mol Cell Cardiol (1990) 0.83
Oxygen supply and oxygen demand in the isolated working rabbit heart perfused with asanguineous crystalloid solution. Cardiovasc Res (1991) 0.83
Effect of glucose on enzyme release from, and recovery of, the anoxic myocardium. Recent Adv Stud Cardiac Struct Metab (1973) 0.83
Inotropic agents and functional recovery from ischemic cardiac arrest. Thorac Cardiovasc Surg (1979) 0.83
Oxidant stress inhibits Na-Ca-exchange current in cardiac myocytes: mediation by sulfhydryl groups? Am J Physiol (1994) 0.83
Na+/H+ exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol (1994) 0.83
R56865, a potent new antiarrhythmic agent, effective during ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol (1990) 0.83
Singlet oxygen-induced arrhythmias. Dose- and light-response studies for photoactivation of rose bengal in the rat heart. Circulation (1989) 0.82
Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection. Cardioscience (1990) 0.82
Ischemic preconditioning: a potential role for constitutive low molecular weight stress protein translocation and phosphorylation? J Mol Cell Cardiol (2000) 0.82
Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit. J Thorac Cardiovasc Surg (1993) 0.82
Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart. J Mol Cell Cardiol (1996) 0.82
Autoradiographic study of the distribution and cellular uptake of (14C) - streptozotocin in the rat. Diabetologia (1976) 0.82
Streptozotocin: its excretion and metabolism in the rat. Diabetologia (1976) 0.82
The application of whole-body autoradiography to a study of the distribution, metabolism and mode of excretion of 35S-labelled aryl sulphate esters. Biochem Pharmacol (1969) 0.82
The genesis of arrhythmias during myocardial ischemia. Dissociation between changes in cyclic adenosine monophosphate and electrical instability in the rat. Circ Res (1985) 0.82
Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia. J Cardiovasc Pharmacol (1987) 0.82